Logo
Q

Quanta Dialysis Technologies

189 employees

Quanta Dialysis Technologies is committed to making high-quality and cost-effective dialysis accessible to every patient in every setting with its Quanta Dialysis System - the first and only FDA-cleared device to perform IHD, SLED, and CRRT (CVVHD and SCUF) without any need for bags. As a compact device with performance comparable to larger traditional machines, the Quanta Dialysis System provides the clinical versatility needed to deliver kidney replacement therapy across multiple care settings. With an intuitive user interface and only once-weekly hot rinse requirement, the device is designed to be operated by a broad range of users to bring dialysis directly to patients. The Royal Academy of Engineering announced Quanta Dialysis Technologies as the recipient of the 2022 MacRobert Award (the UK’s longest running and most prestigious award for UK engineering innovation), joining the ranks of Rolls-Royce, Arup and Raspberry Pi.

Investor insights

Funding rounds participated in

$60M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Funding rounds raised

Total raised

$60M

from 3 investors over 1 rounds

Q

Quanta Dialysis Technologies raised $60M on December 18, 2024

Investors: b2venture, Glenview Capital Management and + 1 Other investor

FAQ